test Ethereum is a blockchain platform with its own cryptocurrency, called Ether (ETH) or Ethereum, and its own programming language, called Solidity. As a blockchain network, Ethereum is a decentralized public ledger for verifying and recording transactions.
Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing small molecule drugs that target novel and critical metabolic pathways in tumor and cancer-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and...
test Bitcoin is a digital currency which operates free of any central control or the oversight of banks or governments. Instead it relies on peer-to-peer software and cryptography.
test Dogecoin is a cryptocurrency, like Bitcoin or Ethereum—although it’s a very different animal than either of these popular coins. Dogecoin was originally created at least in part as a lighthearted joke for crypto enthusiasts, and took its name from a once-popular meme. Despite this unusual origin story, it has exploded in popularity in 2021
Part of the beware series. They pump...They Dump. HeartCore Enterprises, Inc. operates as a software development company. It operates through the following business units: the customer experience management platform and the digital transformation. The customer experience management platform includes marketing, sales, service, and a content management system. The...
test Hyperinflation should kick asset prices to new highs and that includes stock market by 2022-23. Following a 7 Year correction to 2030 That is just my opinion...
The Russell 2000 Index is a small-cap stock market index that makes up the smallest 2,000 stocks in the Russell 3000 Index. It was started by the Frank Russell Company in 1984. The index is maintained by FTSE Russell, a subsidiary of the London Stock Exchange Group.
test Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used...
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands
test Cemtrex, Inc. engages in the provision of solutions in the technology. It operates through the following segments: Advanced Technologies and Industrial Services. The Advanced Technologies segment delivers cutting-edge technologies in the IoT, Wearables and Smart Devices, such as the SmartDesk. It also includes the Company's subsidiary Vicon Industries, which...
test $10.xx 1st $29-31 2nd target Post Split Double Those Targets. Hudson Capital, Inc. operates through its wholly owned subsidiary Freight App, Inc. (Fr8App), which is a North American transportation logistics technology company with a specialty in US-Mexico-Canada cross-border shipping. Powered by AI and big data analytics, the Fr8App platform connects...
test XRP is the native cryptocurrency for products developed by Ripple Labs. Its products are used for payment settlement, asset exchange, and remittance systems that work more like SWIFT, a service for international money and security transfers used by a network of banks and financial intermediaries.
Test 40k is end of wave (3) No it's not a superman short to 21k. Exit wave a. No new updates to this chart since the original publish where I predicted BTC to end 68k+.
test I'm just as curious as anyone...
BitNile Holdings, Inc. engages in the design, development, manufacture, and sale of customized and flexible power system solutions for the medical, military, telecom, and industrial markets. It operates through the following segments: DPC, DPL, Enertec, Digital Farms, and I.AM. The DPC segment includes Microphase, Coolisys, Power-Plus, and DP Lending. The DPL...
Lots of interesting setups with Pharma sector. This one too. Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.